Perceptive Informatics (PI) has added Optasia’ KneeAnalyzer to its clinical offering, positioning itself for the anticipated surge in number of trials examining musculoskeletal drugs over the next few years
The merger between Mitsubishi Chemical Holding's pharmaceutical
unit and Tanabe Seiyaku has been completed and the new entity is
looking to expand its presence outside Japan and create a more
efficient R&D and manufacturing...
The UK's drug reimbursement watchdog has given the green light for
the first time to a treatment specifically for multiple sclerosis
(MS) and also gave the thumbs up to two arthritis drugs, all of
which are biologics.
A drug that holds the potential to 'significantly' improve the
symptoms of rheumatoid arthritis (RA), rather than merely relieve
the pain for the debilitating disorder, is one step
closer to the market.